Breast Neoplasms: all 12,820 studies
Page 99 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated PatientsCompletedNCT01983995
- Effect of Chemotherapy on Pain Sensitivity and Patient-reported SymptomsCompletedNCT01983982
- A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast CancerCompletedNCT01983501Phase 1
- Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT01982591
- Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast CancerCompletedNCT01980823Early Phase 1
- Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast CancerTerminatedNCT01980277Phase 1/2
- Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast CancerCompletedNCT01978977
- Outpatient Clinic for Late Outcome for Breast Carcinoma in MAASTRO Clinic.CompletedNCT01978756
- Prediction of Everolimus-induced Interstitial Lung DiseaseCompletedNCT01978171
- Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated PatientsCompletedNCT01977053Not applicable
- Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)CompletedNCT01976169Phase 1
- Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast CancerTerminatedNCT01975597
- Pilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerCompletedNCT01975363Not applicable
- Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.CompletedNCT01975142Phase 2
- Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaCompletedNCT01975064Phase 4
- A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature AssayCompletedNCT01974856
- PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast CancerCompletedNCT01973660Phase 2
- A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast CancerCompletedNCT01973309Phase 1
- Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer PatientsCompletedNCT01972984Phase 2
- Mobile Phone Multimedia Messaging Intervention for Breast Cancer ScreeningWithdrawnNCT01972048Not applicable
- A Safety Study of SGN-LIV1A in Breast Cancer PatientsCompletedNCT01969643Phase 1
- A Prospective Observational Study of Lymphedema in Breast Cancer With Axillary Lymph Node DissectionCompletedNCT01969253
- Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerCompletedNCT01969032Phase 2
- Anti-proliferative Effects of Vitamin D and Melatonin in Breast CancerCompletedNCT01965522Phase 2
- Phase 2 Study of Adjuvant Radiotherapy in Breast Cancer Using a Once a Week Hypofractionated RegimenCompletedNCT01965483Phase 2
- A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerCompletedNCT01964391Phase 3
- A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast CancerStatus unknownNCT01963572Not applicable
- RPFNA Assessment of Exercise Effect in Breast CancerCompletedNCT01961128Not applicable
- Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)WithdrawnNCT01960803Not applicable
- SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy RadiotherapyWithdrawnNCT01959867Not applicable
- A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast CancerCompletedNCT01959386
- Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer TherapyTerminatedNCT01957514
- IMaging PAtients for Cancer Drug selecTion - Metastatic Breast CancerActive, not recruitingNCT01957332Not applicable
- Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)TerminatedNCT01956552Not applicable
- Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer DiagnosisStatus unknownNCT01956409Phase 4
- Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer PatientsTerminatedNCT01954706Not applicable
- Effectiveness of Accelerated Intervention With Compression Sleeve in Mild and Moderate Breast Cancer-related LymphedemaStatus unknownNCT01954654Not applicable
- Accountability for Cancer Care Through Undoing Racism and EquityCompletedNCT01954641Not applicable
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
- Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)WithdrawnNCT01953536Phase 2
- Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast CancerWithdrawnNCT01953445Phase 2
- PMA Required Pivotal Multi-reader Multi-case Reader StudyCompletedNCT01952717
- Yoga for Aromatase Inhibitor-associated Joint PainCompletedNCT01951976Not applicable
- Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast CancerCompletedNCT01950182Phase 3
- Mild Cognitive Impairment in Breast Cancer PatientsCompletedNCT01949376
- Influence of Exceptional Patient Characteristics on Everolimus ExposureCompletedNCT01948960Phase 4
- Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast CancerCompletedNCT01948843Phase 1
- Hypofractionation With Simultaneous Integrated Boost for Early Breast CancerCompletedNCT01948726Not applicable
- Effects of Vitamin D in Patients With Breast CancerCompletedNCT01948128Phase 2
- Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast CancerCompletedNCT01945476Not applicable
- Supervised Aerobic Training During or After Chemotherapy for Operable Breast CancerActive, not recruitingNCT01943695Not applicable
- Discordant Hormonal Status of Breast Cancer.CompletedNCT01943032
- Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast CancerCompletedNCT01942980Phase 3
- The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast CancerCompletedNCT01942759
- Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing ChemotherapyCompletedNCT01941784Not applicable
- Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast CancerCompletedNCT01941771Phase 2
- First Line Metastatic Breast Cancer Treatment (ESMERALDA)CompletedNCT01941407Phase 2
- IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns HopkinsCompletedNCT01939847Not applicable
- A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesWithdrawnNCT01939483Not applicable
- Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast CancerTerminatedNCT01939418Phase 1/2
- Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer PatientsStatus unknownNCT01939054Phase 2
- Ultra High Field MRI and MRS Techniques in Diagnosing Breast CancerTerminatedNCT01938651Not applicable
- Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot StudyCompletedNCT01938157Not applicable
- Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast CancerCompletedNCT01937689Phase 1
- Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal DatabaseCompletedNCT01937052
- Johns Hopkins Breast Cancer Program Longitudinal RepositoryActive, not recruitingNCT01937039
- The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer PatientsStatus unknownNCT01936064Phase 1/2
- Discordant HER2/Neu Status of Breast Cancer.CompletedNCT01935739
- 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast CancerCompletedNCT01935492Phase 3
- Polymorphism Interaction to Predict Bevacizumab EfficacyCompletedNCT01935102
- Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast CancerCompletedNCT01934478
- NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in VivoTerminatedNCT01934114
- A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast CancerStatus unknownNCT01931943Phase 1
- Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital MammographyCompletedNCT01928992
- Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast CancerActive, not recruitingNCT01928589Not applicable
- 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.Status unknownNCT01927939
- Self-management Interventions for Advanced Breast CancerCompletedNCT01927081Not applicable
- Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast CancerCompletedNCT01926964
- Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast CancerCompletedNCT01925651Not applicable
- HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)WithdrawnNCT01924351Phase 2
- Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerStatus unknownNCT01924078Phase 2
- Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation DermatitisStatus unknownNCT01923220Early Phase 1
- ARRY-380 + Trastuzuamab for Breast w/ Brain MetsCompletedNCT01921335Phase 1
- Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary LymphadenopathyCompletedNCT01920139Not applicable
- A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast CancerCompletedNCT01919749Not applicable
- A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 ProteinCompletedNCT01918254Phase 1
- Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI ReconstructionStatus unknownNCT01917578Phase 3
- Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCStatus unknownNCT01917279Phase 3
- Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast CancerCompletedNCT01916837
- A Pilot Study of Working Women and Breast CancerCompletedNCT01914614
- Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
- Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesTerminatedNCT01910870Phase 2
- Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesTerminatedNCT01910844Phase 2
- Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense BreastsCompletedNCT01910103
- Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)Status unknownNCT01908556Phase 4
- Effects of Yoga on Menopausal Symptoms in Women With Breast CancerCompletedNCT01908270Not applicable
- Exercise and Radiotherapy, a Good Combination?CompletedNCT01908023Not applicable
- The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast CancerCompletedNCT01907880Phase 4
- A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast CancerStatus unknownNCT01907529Phase 2/3
- Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.WithdrawnNCT01906112Phase 3